Kenvue Inc. (NYSE:KVUE) Shares Bought by Wills Financial Group Inc.

Wills Financial Group Inc. lifted its position in Kenvue Inc. (NYSE:KVUE - Free Report) by 15.8% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 280,606 shares of the company's stock after buying an additional 38,340 shares during the period. Kenvue makes up about 2.6% of Wills Financial Group Inc.'s investment portfolio, making the stock its 11th biggest position. Wills Financial Group Inc.'s holdings in Kenvue were worth $5,991,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. Susquehanna Fundamental Investments LLC purchased a new stake in shares of Kenvue in the fourth quarter worth $5,117,000. Coldstream Capital Management Inc. boosted its stake in Kenvue by 2.5% in the 4th quarter. Coldstream Capital Management Inc. now owns 26,673 shares of the company's stock worth $569,000 after purchasing an additional 656 shares during the period. Voya Investment Management LLC raised its position in shares of Kenvue by 22.1% during the fourth quarter. Voya Investment Management LLC now owns 5,244,684 shares of the company's stock valued at $111,974,000 after buying an additional 950,315 shares during the last quarter. Sirios Capital Management L P bought a new stake in Kenvue in the 4th quarter valued at $423,000. Finally, MGO One Seven LLC raised its stake in Kenvue by 12.2% during the fourth quarter. MGO One Seven LLC now owns 37,771 shares of the company's stock valued at $806,000 after purchasing an additional 4,116 shares in the last quarter. Institutional investors own 97.64% of the company's stock.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on KVUE shares. Piper Sandler raised their price target on Kenvue from $24.00 to $27.00 and gave the stock an "overweight" rating in a research report on Monday, February 24th. Canaccord Genuity Group lifted their price target on shares of Kenvue from $24.00 to $29.00 and gave the stock a "buy" rating in a research note on Wednesday, March 5th. Evercore ISI initiated coverage on shares of Kenvue in a research report on Monday, March 24th. They issued an "in-line" rating and a $25.00 price objective on the stock. Redburn Atlantic initiated coverage on Kenvue in a research report on Thursday, April 10th. They set a "neutral" rating and a $23.50 target price for the company. Finally, Barclays decreased their price target on Kenvue from $23.00 to $22.00 and set an "equal weight" rating for the company in a research note on Monday, April 14th. Eight research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of "Hold" and a consensus price target of $24.42.

Kenvue Stock Up 1.1 %

Kenvue stock traded up $0.27 during mid-day trading on Thursday, reaching $23.87. 5,508,689 shares of the company were exchanged, compared to its average volume of 15,721,662. Kenvue Inc. has a 12-month low of $17.67 and a 12-month high of $24.46. The business has a fifty day moving average of $23.07 and a 200 day moving average of $22.47. The firm has a market cap of $45.79 billion, a P/E ratio of 45.03, a PEG ratio of 2.62 and a beta of 1.02. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.69 and a current ratio of 1.00.

Kenvue (NYSE:KVUE - Get Free Report) last issued its quarterly earnings data on Thursday, February 6th. The company reported $0.26 earnings per share for the quarter, meeting analysts' consensus estimates of $0.26. Kenvue had a return on equity of 20.97% and a net margin of 6.66%. Research analysts anticipate that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.

Kenvue Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 28th. Investors of record on Wednesday, May 14th will be paid a dividend of $0.205 per share. The ex-dividend date of this dividend is Wednesday, May 14th. This represents a $0.82 annualized dividend and a dividend yield of 3.44%. Kenvue's dividend payout ratio (DPR) is presently 154.72%.

Kenvue Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.